Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

This study explores how living with multiple stigmatized identities impacts substance use recovery among people with a migration background and ethnic minorities (MEM).

Original research | 2022
Equity, Stigma

Intravenous buprenorphine for the treatment of OUD (BUP iOAT) has several possible advantages over traditional iOAT, including a safety profile that might enable take-home dosing.

Lit review | 2022
Injecting drugs, Substitution/OAT

Our aim was to publish an interactive summary of all peer-reviewed interventional and observational trials assessing the treatment of OUD and common clinical outcomes.

Original research | 2022
Substitution/OAT, Evidence base

The COVID-19 pandemic has impacted supervised consumption site (SCS) operations in Montréal, Canada, potentially including changes in SCS visits, on-site emergency interventions, injection of speci

Original research | 2022
SCS/OPS, Overdose, Illegal drugs
Guide or handbook | 2022
SCS/OPS, About prescribers, Wrap-around services, Legal system/law enforcement, Policy/Regulatory, Illegal drugs
Training | 2022
Mental health, Workplace, Peer/PWLLE program involvement

The present study was conducted to estimate the association between measures of hope for the future and time to substance use relapse among people living with opioid dependence following their disc

Original research | 2022
About PWUD, Mental health

In this study, we describe the drug use practices — including access to and use of on-site supervised consumption, OAT, and prescribed safer supply medications — of study participants living in per

Original research | 2022
Housing, SCS/OPS, About PWUD, Safer supply, Evidence base, Wrap-around services, Crime

The rapid increase in fentanyl overdose deaths, particularly those also attributed to stimulants, has led to concerns about unintentional fentanyl exposure.

Original research | 2022
Overdose, Mortality, About PWUD
Report | 2020
Harm reduction, Peer/PWLLE program involvement
Guide or handbook | 2018
Harm reduction, Peer/PWLLE program involvement
Training | 2022
Peer/PWLLE program involvement

In the context of a large publicly funded behavioral health system, we examined the relationship between a range of implementation barriers and a substance use disorder treatment agency's level of

Original research | 2022
About prescribers, Substitution/OAT
Guide or handbook | 2022
Harm reduction, Policy/Regulatory

Contributors to overdose mortality vary with changing patterns of substance use and updating overdose and mortality statistics may help focus resources for persons released from prison.

Original research | 2022
About PWUD, Legal system/law enforcement, Mortality

Safer supply – low-barrier distribution of pharmaceutical grade substances – has been implemented in some jurisdictions to provide safer alternatives to the unregulated drug supply, yet no studies

Original research | 2022
About prescribers, Safer supply, Equity, Decriminalization/legalization, Stigma, Policy/Regulatory, Hesitancy of prescribers , Barriers and enablers

Drug users should be at the centre of program and policy decisions related to the development and implementation of safer supply.

Original research | 2022
About PWUD, Safer supply, Barriers and enablers

Recovery management checkups (RMC) have established efficacy for linking patients to substance use disorder (SUD) treatment.

Original research | 2022
Wrap-around services, Outcomes, Transitions in care/treatment

Refine Your Search

Keywords
Format
Region